Combinations Against Combinations: Associations of Anti-HIV 1 Reverse Transcriptase Drugs Challenged by Constellations of Drug Resistance Mutations

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|3|1|73-95

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.3, Iss.1, 2002-02, pp. : 73-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Action of Anti-HIV Drugs and Resistance: Reverse Transcriptase Inhibitors and Protease Inhibitors

By  

Current Pharmaceutical Design, Vol. 10, Iss. 32, 2004-12 ,pp. : 4039-4053

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 1, 2013-01 ,pp. : 27-34

Bentham Science Publishers

Access to resources Recommend Favorite

Novel C-organosilicon derivatives as leads for reverse-transcriptase-mediated anti-HIV-1 activity

By Delord B.   Guillorit M.   Lafay J.   Andreola M.   Tharaud D.   Tarrago-Litvak L.   Fleury H.   Deleris G.  

European Journal of Medicinal Chemistry, Vol. 31, Iss. 2, 1996-01 ,pp. : 111-122

Elsevier

Access to resources Recommend Favorite

A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

By  

Current Pharmaceutical Design, Vol. 21, Iss. 7, 2015-02 ,pp. : 925-935

Bentham Science Publishers

Access to resources Recommend Favorite

Insertions and Deletions in HIV-1 Reverse Transcriptase: Consequences for Drug Resistance and Viral Fitness

By  

Current Pharmaceutical Design, Vol. 12, Iss. 15, 2006-01 ,pp. : 1811-1825

Bentham Science Publishers

Access to resources Recommend Favorite